William S. Dalton

Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma

Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster et al. · New England Journal of Medicine · 2005 · 2.5K citations · Full text

Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

Robyn Catlett-Falcone, Terry H. Landowski, Marc M. Oshiro et al. · Immunity · 1999 · 1.6K citations · Full text

Cell Regulation, Constitutive Activation, Medicine +8

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

Tianhong Wang, Guilian Niu, Marcin Kortylewski et al. · Nature Medicine · 2003 · 1.1K citations

Inflammation, Cytokine, Cancer Immunosurveillance +15

MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA

William Kong, Hua Yang, Lili He et al. · Molecular and Cellular Biology · 2008 · 686 citations · Full text

Cancer Biology, Mammary Gland Development, Tumor Biology +19

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

Paul G. Richardson, Emily Blood, Constantine S. Mitsiades et al. · Blood · 2006 · 520 citations · Full text